CRISPR–Cas9 genome editing is used to induce a DNA repair response and correct a disease-causing heterozygous mutation in human embryos with reduced mosaicism and preferential repair using the wild-type copy of the gene.
- Hong Ma
- Nuria Marti-Gutierrez
- Shoukhrat Mitalipov